Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine

Headache

Volumn 47, Issue 6, 2007, Pages 842-847

  Vieira, Domingos Sávio DeSouza ^a,b   Naffah Mazzacoratti, Maria Da Graça ^b   Zukerman, Eliova ^a   Soares, Carlos Augusto Senne ^a   Cavalheiro, Esper Abräo ^a,b   Peres, Mario Fernando Prieto ^a,b,c  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Glutamate; Migraine; Overuse; Triptans

Indexed keywords

ANALGESIC AGENT; CAFFEINE; DIPYRONE; GLUTAMIC ACID; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; ORPHENADRINE; RIZATRIPTAN; TRIPTAN DERIVATIVE;

ARTICLE; BRAZIL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MISUSE; HUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; STATISTICAL SIGNIFICANCE; TRANSFORMED MIGRAINE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GLUTAMIC ACID; HEADACHE DISORDERS; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PIPERIDINES; SEROTONIN AGONISTS; TRIAZOLES; TRYPTAMINES;

EID: 34250681460     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00812.x     Document Type: Article

References (36)

1. Kavuk I, Yavuz A, Cetindere U, Agelink MW, Diener HC. Epidemiology of chronic daily headache. Eur J Med Res. 2003 8 : 236 240.
2. Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia. 2004 24 (suppl 2 2 7.
3. Ramadan NM. The link between glutamate and migraine. CNS Spectr. 2003 8 : 446 449.
4. Martinez F, Castillo J, Rodriguez JR, Leira R, Nova M. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia. 1993 13 : 89 93.
5. Zukerman E, Minatti-Hanuch S, Mazzacoratti M, dos Reis Filho J, Cavalheiro EA. CSF aminoacids in migraine. Cephalalgia. 1993 13 (suppl 13 92.
6. Gallai V, Alberti A, Gallai B, Coppola F, Floridi A, Sarchelli P. Glutamate and nitric oxide pathway in chronic daily headache: Evidence from cerebrospinal fluid. Cephalalgia 2003 23 : 166 174.
7. Peres MF, Young WB, Kaup AO, Zukerman E, Silberstein SD. Fibromyalgia is common in patients with transformed migraine. Neurology. 2001 57 : 1326 1328.
8. Lainez M. Clinical benefits of early triptan therapy for migraine. Cephalalgia 2004 24 (suppl 2 24 30.
9. Peres MF, Zukerman E, Senne Soares CA, Alonso EO, Santos BF, Faulhaber MH. Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 2004 24 : 735 739.
10. Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004 24 (suppl 1 9 160.
11. Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology. 1996 46 : 1226 1230.
12. Quattrone A, Bono F, Oliveri RL, Gambardella A, Pirritano D, Labate A, et al. Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH. Neurology. 2001 57 : 31 36.
13. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 26 : 742 746.
14. Cavalheiro EA, Fernandes MJ, Turski L, Naffah-Mazzacoratti MG. Spontaneous recurrent seizures in rats: Amino acid and monoamine determination in the hippocampus. Epilepsia. 1994 35 : 1 11.
15. Baranauskas G, Nistri A. Sensitization of pain pathways in the spinal cord: Cellular mechanisms. Prog Neurobiol. 1998 54 : 349 365.
16. Urban MO, Gebhart GF. Central mechanisms in pain. Med Clin North Am. 1999 83 : 585 596.
17. Alam Z, Coombes N, Waring RH, Williams AC, Steventon GB. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Sci. 1998 156 : 102 106.
18. Cananzi AR, D'Andrea G, Perini F, Zamberlan F, Welch KM. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia. 1995 15 : 132 135.
19. D'Andrea G, Cananzi AR, Joseph R, Morra M, Zamberlan F, Ferro Milone F, et al. Platelet glycine, glutamate and aspartate in primary headache. Cephalalgia. 1991 11 : 197 200.
20. D'Eufemia P, Finocchiaro R, Lendvai D, Celli M, Viozzi L, Troiani P, et al. Erythrocyte and plasma levels of glutamate and aspartate in children affected by migraine. Cephalalgia. 1997 17 : 652 657.
21. Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology. 1990 40 : 1582 1586.
22. Aanonsen LM, Lei S, Wilcox GL. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain. 1990 41 : 309 321.
23. Bennett GJ. Update on the neurophysiology of pain transmission and modulation: Focus on the NMDA-receptor. J Pain Symptom Manage. 2000 19 (suppl 1 S2 6.
24. Coderre TJ, Yashpal K. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur J Neurosci. 1994 6 : 1328 1334.
25. Harris JA, Corsi M, Quartaroli M, Arban R, Bentivoglio M. Upregulation of spinal glutamate receptors in chronic pain. Neuroscience. 1996 74 : 7 12.
26. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000 123 (Pt 8 1703 1709.
27. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol. 2000 47 : 614 624.
28. Burstein R, Collins B, Bajwa ZH, Zakubowski M. Triptan therapy can abort attacks if given before the establishment or in the presence of cutaneous allodynia and central sensitization: Clinical and preclinical evidence. Headache. 2002 42 : 389.
29. Burstein R, Levy D, Jakubowski M. Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine. Rev Neurol (Paris). 2005 161 : 658 660.
30. Cady RK, Lipton RB, Hall C, Stewart WF, O'Quinn S, Gutterman D. Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum Study. Headache. 2000 40 : 792 797.
31. Pascual J, Cabarrocas X. Within-patient early versus delayed treatment of migraine attacks with almotriptan: The sooner the better. Headache. 2002 42 : 28 31.
32. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: A race against the development of cutaneous allodynia. Ann Neurol. 2004 55 : 19 26.
33. Goadsby PJ, Akerman S, Storer RJ. Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex. Ann Neurol. 2001 50 : 804 807.
34. Ma QP. Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats. Neuroreport. 2001 12 : 1589 1591.
35. Mitsikostas DD, Sanchez del Rio M, Waeber C, Huang Z, Cutrer FM, Moskowitz MA. Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis. Br J Pharmacol. 1999 127 : 623 630.
36. Storer RJ, Goadsby PJ. Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience. 1999 90 : 1371 1376.